Literature DB >> 10526906

Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index.

T Kazumi1, A Kawaguchi, J Katoh, M Iwahashi, G Yoshino.   

Abstract

OBJECTIVE: To examine the relationship between leptin and insulin serum levels and systolic and diastolic blood pressure in young men.
SETTING: Kobe University of Mercantile Marine, Kobe, Japan. PARTICIPANTS: One hundred and ninety-eight male students aged 18-20 years (comprising 100% of those eligible). DESIGN AND MEASUREMENTS: A cross-sectional survey of a sample of male college students was performed, with measurements to include anthropometry, blood pressure and blood tests after overnight fasting.
RESULTS: Compared with 90 men with an optimal blood pressure, 56 men with high-normal and high blood pressure had an increase in body mass index (23.7 +/- 5.2 versus 20.4 +/- 2.2 kg/m2), percentage body fat (21.7 +/- 8.0 versus 16.3 +/- 4.2%) and serum leptin (3.7 +/- 4.7 versus 1.5 +/- 0.8 ng/ml). In addition, they had greater serum insulin (59 +/- 31 versus 43 +/- 12 pmol/l) despite there being no differences in plasma glucose, resulting in a reduction of the ratio of glucose to insulin (x 10(6)) (107 +/- 43 versus 126 +/-, which is an estimate of insulin sensitivity in a nondiabetic population. Furthermore, the 56 men had higher serum triglyceride levels, although there was no difference in low density lipoprotein-cholesterol and high density lipoprotein-cholesterol between men with optimal and high-normal plus high blood pressure. Similar differences were found between men in a top versus low tertile of systolic and diastolic blood pressure. In multiple regression analysis, both log leptin and log insulin emerged as determinants for systolic blood pressure independent of body mass index and percentage body fat, but an association with diastolic blood pressure was only shown for log leptin.
CONCLUSION: Hyperleptinemia and hyperinsulinemia may be regulators of arterial pressure, independent of body mass index or percentage body fat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526906     DOI: 10.1097/00004872-199917100-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Insulin resistance and the metabolic syndrome.

Authors:  L Landsberg
Journal:  Diabetologia       Date:  2005-07       Impact factor: 10.122

Review 2.  The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.

Authors:  Peminda K Cabandugama; Michael J Gardner; James R Sowers
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

Review 3.  Childhood adversity and mechanistic links to hypertension risk in adulthood.

Authors:  Ijeoma E Obi; Kasi C McPherson; Jennifer S Pollock
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

4.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

Review 5.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 6.  Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.

Authors:  Sanjeev B Patel; Garry P Reams; Robert M Spear; Ronald H Freeman; Daniel Villarreal
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

Review 7.  Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.

Authors:  Lewis Landsberg; Louis J Aronne; Lawrence J Beilin; Valerie Burke; Leon I Igel; Donald Lloyd-Jones; James Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-18       Impact factor: 3.738

8.  Leptin regulates CD16 expression on human monocytes in a sex-specific manner.

Authors:  Joseph G Cannon; Gyanendra Sharma; Gloria Sloan; Christiana Dimitropoulou; R Randall Baker; Andrew Mazzoli; Barbara Kraj; Anthony Mulloy; Miriam Cortez-Cooper
Journal:  Physiol Rep       Date:  2014-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.